Mixed Chimera Allogeneic Transplantation From Matched Unrelated Donors for the Treatment of Multiple Myeloma
The primary objective of the protocol is to evaluate the toxicity and tolerability of this
mixed chimerism matched unrelated donor allogeneic transplant approach for patients with
multiple myeloma. Response, toxicity, survival and graft-versus-host disease will be
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Feasibility and laboratory-measured efficacy of mixed chimera unrelated donor allogeneic transplants.
United States: Institutional Review Board
|Stanford University School of Medicine||Stanford, California 94305-5317|